Book contents
- The Cambridge Handbook of Compliance
- The Cambridge Handbook of Compliance
- Copyright page
- Contents
- Figures
- Tables
- Contributors
- 1 Introduction: Compliance as the Interaction between Rules and Behavior
- Part I Compliance Concepts and Approaches
- Part II Deterrence and Incapacitation
- Part III Incentives
- Part IV Legitimacy and Social Norms
- Part V Capacity and Opportunity
- Part VI Compliance and Cognition
- Part VII Management and Organizational Processes
- Part VIII Measuring and Evaluating Compliance
- Part IX Analysis of Particular Fields
- 55 Strengthening Tax Compliance by Balancing Authorities’ Power and Trustworthiness
- 56 Compliance in Occupational Safety and Health
- 57 Intellectual Property Compliance: Systematic Methods for Building and Using Intellectual Property
- 58 Insider Trading Compliance Programs
- 59 Antitrust Compliance: Collusion
- 60 Understanding AI Collusion and Compliance
- 61 HIPAA Compliance
- 62 Biopharmaceutical Compliance
- 63 Transnational Anti-Bribery Law
- 64 Data Security, Data Breaches, and Compliance
- 65 Doping in Sports: A Compliance Conundrum
- 66 Food Safety Compliance
- 67 Global Supply Chain Auditing
- 68 Corporations, Human Rights and Compliance
- 69 Aiming for Integrity with Integrity
- References
65 - Doping in Sports: A Compliance Conundrum
from Part IX - Analysis of Particular Fields
Published online by Cambridge University Press: 07 May 2021
Book contents
- The Cambridge Handbook of Compliance
- The Cambridge Handbook of Compliance
- Copyright page
- Contents
- Figures
- Tables
- Contributors
- 1 Introduction: Compliance as the Interaction between Rules and Behavior
- Part I Compliance Concepts and Approaches
- Part II Deterrence and Incapacitation
- Part III Incentives
- Part IV Legitimacy and Social Norms
- Part V Capacity and Opportunity
- Part VI Compliance and Cognition
- Part VII Management and Organizational Processes
- Part VIII Measuring and Evaluating Compliance
- Part IX Analysis of Particular Fields
- 55 Strengthening Tax Compliance by Balancing Authorities’ Power and Trustworthiness
- 56 Compliance in Occupational Safety and Health
- 57 Intellectual Property Compliance: Systematic Methods for Building and Using Intellectual Property
- 58 Insider Trading Compliance Programs
- 59 Antitrust Compliance: Collusion
- 60 Understanding AI Collusion and Compliance
- 61 HIPAA Compliance
- 62 Biopharmaceutical Compliance
- 63 Transnational Anti-Bribery Law
- 64 Data Security, Data Breaches, and Compliance
- 65 Doping in Sports: A Compliance Conundrum
- 66 Food Safety Compliance
- 67 Global Supply Chain Auditing
- 68 Corporations, Human Rights and Compliance
- 69 Aiming for Integrity with Integrity
- References
Summary
Abstract: This chapter reviews the history of doping regulations, contemporary anti-doping policies and the effectiveness thereof, as well as the public’s perception of the current state of doping in sports. We discuss how detection, testing and punishment influence compliance and, ultimately, the prevalence of doping. We offer a general framework to understand why anti-doping objectives are difficult to achieve. Finally, we assess some of the proposed solutions to improve current anti-doping policies.
- Type
- Chapter
- Information
- The Cambridge Handbook of Compliance , pp. 949 - 961Publisher: Cambridge University PressPrint publication year: 2021
References
Athey, Susan, and Imbens, Guido W.. 2017. ‘The State of Applied Econometrics: Causality and Policy Evaluation’. Journal of Economic Perspectives 31, no. 2: 3–32. DOI: 10.1257/jep.31.2.3.CrossRefGoogle Scholar
Berry, Donald A. 2008. ‘The Science of Doping’. Nature 454, no. 7205: 692. DOI: 10.1038/454692a.Google Scholar
Cisyk, Jeffrey. 2020. ‘Impacts of Performance-Enhancing Drug Suspensions on the Demand for Major League Baseball’. Journal of Sports Economics 21, no. 4: 391–419. DOI: 10.1177/1527002520906529.Google Scholar
Cisyk, Jeffrey, and Courty, Pascal. 2017. ‘Do Fans Care about Compliance to Doping Regulations in Sports? The Impact of PED Suspension in Baseball’. Journal of Sports Economics 18, No. 4: 323–50. DOI: 10.1177/1527002515587441.CrossRefGoogle Scholar
Connor, James, Woolf, Jules, and Mazanov, Jason. 2013. ‘Would They Dope? Revisiting the Goldman Dilemma’. British Journal of Sports Medicine 47, No. 11: 697–700. DOI: 10.1136/bjsports-2012-091826.Google Scholar
de Hon, Olivier, Kuipers, Harm, and van Bottenburg, Maarten. 2015. ‘Prevalence of Doping Use in Elite Sports: A Review of Numbers and Methods’. Sports Medicine 45, No. 1: 57–69. DOI: 10.1007/s40279-014-0247-x.Google Scholar
Delanghe, Joris R., Maenhout, Thomas M., Speeckaert, M. M., and De Buyzere, Marijn L.. 2014. ‘Detecting Doping Use: More Than an Analytical Problem’. Acta Clinica Belgica 69, No. 1: 25–9. DOI: 10.1179/0001551213Z.0000000009.Google Scholar
Goldman, Bob, Bush, Patricia J., and Klatz, Ronald. 1984. Death in the Locker Room: Steroids and Sports. London: Century.Google Scholar
Hermann, Aaron, and Henneberg, Maciej. 2014. ‘Anti-doping Systems in Sports Are Doomed to Fail: A Probability and Cost Analysis’. Journal of Sports Medicine & Doping 4, No. 5: 148. DOI: 10.4172/2161-0673.1000148.Google Scholar
Isenmann, Eduard, Ambrosio, Gabriella, Joseph, Jan Felix, Mazzarino, Monica, de la Torre, Xavier, Zimmer, Philipp, Kazlauskas, Rymantas et al. 2019. ‘Ecdysteroids as Non-conventional Anabolic Agent: Performance Enhancement by Ecdysterone Supplementation in Humans’. Archives of Toxicology 93, No. 7: 1–10. DOI: 10.1007/s00204-019-02490-x.g.Google Scholar
Kayser, Bengt, Mauron, Alexandre, and Miah, Andy. 2007. ‘Current Anti-doping Policy: A Critical Appraisal’. BMC Medical Ethics 8, No. 1: 2. DOI: 10.1186/1472-6939-8-2.Google Scholar
Maennig, Wolfgang. 2014. ‘Inefficiency of the Anti-doping System: Cost Reduction Proposals’. Substance Use & Misuse 49, No. 9: 1201–5. DOI: 10.3109/10826084.2014.912065.CrossRefGoogle ScholarPubMed
Mazanov, Jason, and Connor, James. 2010. ‘Rethinking the Management of Drugs in Sport’. International Journal of Sport Policy 2, No. 1: 49–63. DOI: 10.1080/19406941003634032.CrossRefGoogle Scholar
Mazanov, Jason, Huybers, Twan, and Connor, James. 2011. ‘Qualitative Evidence of a Primary Intervention Point for Elite Athlete Doping’. Journal of Science and Medicine in Sport 14, No. 2: 106–10. DOI: 10.1016/j.jsams.2010.06.003.Google Scholar
Mitchell, George John. 2007. ‘Report to the Commissioner of Baseball of an Independent Investigation into the Illegal Use of Steroids and Other Performance Enhancing Substances by Players in Major League Baseball’.Google Scholar
Møller, Verner. 2016. ‘The Road to Hell Is Paved with Good Intentions – A Critical Evaluation of WADA’s Anti-doping Campaign’. Performance Enhancement & Health 4, no. 3–4: 111–15. DOI: 10.1016/j.peh.2016.05.001.Google Scholar
Mountjoy, Margo, Miller, Stuart, Vallini, Matteo, Foster, Jeremy, and Carr, James. 2017. ‘International Sports Federation’s Fight to Protect the Clean Athlete: Are We Doing Enough in the Fight against Doping?’ British Journal of Sports Medicine 51: 1241–1242. DOI: 10.1136/bjsports-2017-097870.CrossRefGoogle ScholarPubMed
Müller, Rudhard Klaus. 2010. ‘History of Doping and Doping Control’. Doping in Sports: Biochemical Principles, Effects and Analysis 195: 1–23. DOI: 10.1007/978-3-540-79088-4_1.Google Scholar
Overbye, Marie, Knudsen, Mette Lykke, and Pfister, Gertrud. 2013. ‘To Dope or Not to Dope: Elite Athletes’ Perceptions of Doping Deterrents and Incentives.’ Performance Enhancement & Health 2, no. 3: 119–34. DOI: 10.1016/j.peh.2013.07.001.Google Scholar
Pielke, Roger. 2018. ‘Assessing Doping Prevalence Is Possible: So What Are We Waiting For?’ Sports Medicine 48, No. 1: 207–9. DOI: 10.1007/s40279-017-0792-1.CrossRefGoogle ScholarPubMed
Pitsch, Werner. 2009. ‘“The Science of Doping” Revisited: Fallacies of the Current Anti-doping Regime’. European Journal of Sport Science 9, No. 2: 87–95. DOI: 10.1080/17461390802702309.CrossRefGoogle Scholar
Pitsch, Werner, and Emrich, Eike. 2011. ‘The Frequency of Doping in Elite Sport: Results of a Replication Study’. International Review for the Sociology of Sport 47, No. 5: 559–580. DOI: 10.1177/1012690211413969.CrossRefGoogle Scholar
Rosen, Sherwin. 1981. ‘The Economics of Superstars’. American Economic Review 71, No. 5: 845–58. www.jstor.org/stable/1803469.Google Scholar
Ulrich, Rolf, Pope, Harrison G., Cléret, Léa, Petróczi, Andrea, Nepusz, Tamás, Schaffer, Jay, Kanayama, Gen, Comstock, R. Dawn, and Simon, Perikles. 2018. ‘Doping in Two Elite Athletics Competitions Assessed by Randomized-Response Surveys’. Sports Medicine 48, No. 1: 211–19. DOI: 10.1007/s40279-017-0765-4.CrossRefGoogle ScholarPubMed
Van Reeth, Daam. 2013. ‘TV Demand for the Tour de France: The Importance of Stage Characteristics versus Outcome Uncertainty, Patriotism, and Doping’. International Journal of Sport Finance 8, No. 1: 39–60.Google Scholar
Vlad, Robert Alexandru, Hancu, Gabriel, Popescu, Gabriel Cosmin, and Lungu, Ioana Andreea. 2018. ‘Doping in Sports, a Never-Ending Story?’ Advanced Pharmaceutical Bulletin 8, No. 4: 529. DOI: 10.15171/apb.2018.062.CrossRefGoogle ScholarPubMed
World Anti-Doping Agency. 2019. ‘Athlete Biological Passport Operating Guidelines’. www.wada-ama.org/en/resources/athlete-biological-passport/athlete-biological-passport-abp-operating-guidelines.Google Scholar
- 1
- Cited by